These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 38798867)
41. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry). Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071 [TBL] [Abstract][Full Text] [Related]
42. Pulmonary arterial hypertension and microRNAs--an ever-growing partnership. Wang Y; Xue XY; Liu YX; Wang KF; Zang XF; Wang J; Wang PL; Zhang J; Pan L; Zhang SY; Wang JX Arch Med Res; 2013 Oct; 44(7):483-7. PubMed ID: 24051036 [TBL] [Abstract][Full Text] [Related]
43. [Research progress on bioinformatics in pulmonary arterial hypertension]. Peng W; Zhang ZY; Xiao YB Zhongguo Dang Dai Er Ke Za Zhi; 2024 Apr; 26(4):425-431. PubMed ID: 38660909 [TBL] [Abstract][Full Text] [Related]
44. microRNA and Pulmonary Hypertension. Boucherat O; Potus F; Bonnet S Adv Exp Med Biol; 2015; 888():237-52. PubMed ID: 26663186 [TBL] [Abstract][Full Text] [Related]
45. Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Kozlik-Feldmann R; Hansmann G; Bonnet D; Schranz D; Apitz C; Michel-Behnke I Heart; 2016 May; 102 Suppl 2():ii42-8. PubMed ID: 27053697 [TBL] [Abstract][Full Text] [Related]
46. Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease. van der Feen DE; Bartelds B; de Boer RA; Berger RMF Eur Heart J; 2017 Jul; 38(26):2034-2041. PubMed ID: 28369399 [TBL] [Abstract][Full Text] [Related]
47. MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling. Zhang Y; Peng B; Han Y Biomed Pharmacother; 2018 Jul; 103():1279-1286. PubMed ID: 29864909 [TBL] [Abstract][Full Text] [Related]
48. miR-1226-3p Promotes eNOS Expression of Pulmonary Arterial Endothelial Cells to Mitigate Hypertension in Rats via Targeting Profilin-1. Jian J; Xia L Biomed Res Int; 2021; 2021():1724722. PubMed ID: 34778448 [TBL] [Abstract][Full Text] [Related]
49. [Impact of composite clinical worsening events on outcome of patients with pulmonary arterial hypertension associated with congenital heart disease]. Xu ZY; Zhang HS; Li QQ; Zhang C; Gu H Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):282-288. PubMed ID: 35340148 [No Abstract] [Full Text] [Related]
50. miRNAs in PAH: biomarker, therapeutic target or both? Meloche J; Pflieger A; Vaillancourt M; Graydon C; Provencher S; Bonnet S Drug Discov Today; 2014 Aug; 19(8):1264-9. PubMed ID: 24881781 [TBL] [Abstract][Full Text] [Related]
53. The HIF-1α/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy. Ma C; Xu Q; Huang S; Song J; Sun M; Zhang J; Chu G; Zhang B; Bai Y; Zhao X; Wang Z; Li P FASEB J; 2023 May; 37(5):e22906. PubMed ID: 37052859 [TBL] [Abstract][Full Text] [Related]
54. Clinical diagnostic value of circulating serum miR-509-3p in pulmonary arterial hypertension with congenital heart disease. Tang P Hellenic J Cardiol; 2020; 61(1):26-30. PubMed ID: 29890280 [TBL] [Abstract][Full Text] [Related]
55. Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension. Zhou J; Li F; Yang Y Respir Res; 2022 Aug; 23(1):223. PubMed ID: 36042446 [TBL] [Abstract][Full Text] [Related]
56. Neuroblastoma Suppressor of Tumorigenicity 1 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension Related to Congenital Heart Disease. Wen B; Peng R; Kong P; Li Z; Liu Y; Ouyang W; Xie Y; Hu X; Wang Q; Pan X Am J Respir Cell Mol Biol; 2022 Dec; 67(6):666-679. PubMed ID: 36169661 [TBL] [Abstract][Full Text] [Related]
57. Accuracy of Doppler echocardiography in the assessment of pulmonary arterial hypertension in patients with congenital heart disease. Wang B; Feng Y; Jia LQ; Wu XL; Li DD; Zhou HX; Yang J; Liang BM; Wang L; Cui KJ; Huang H; Yi Q Eur Rev Med Pharmacol Sci; 2013 Apr; 17(7):923-8. PubMed ID: 23640439 [TBL] [Abstract][Full Text] [Related]
58. Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies. D'Alto M; Diller GP Heart; 2014 Sep; 100(17):1322-8. PubMed ID: 24829371 [TBL] [Abstract][Full Text] [Related]
59. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study. Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027 [TBL] [Abstract][Full Text] [Related]